Product image of Betafact (Human Coagulation Factor Ix) supplied by GNH India

Betafact

Active Ingredient:
Human Coagulation Factor Ix
Origin:
EU

Betafact (Human Coagulation Factor Ix)

Betafact is a human coagulation factor IX used to manage bleeding in hemophilia B. This intravenous medication supports blood clotting for effective treatment.

Manufacturer / TM Owner

Lfb Biomedicaments

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Betafact is primarily used to control bleeding episodes in individuals with hemophilia B, a condition where the body lacks sufficient factor IX. It helps replace the missing clotting factor to promote normal blood coagulation. This medication is essential for managing bleeding episodes and can also be used for surgical prophylaxis to prevent excessive bleeding during procedures.

Side Effects

  • Betafact works by replacing the missing factor IX in the blood, which is crucial for the clotting process. This helps to stop bleeding episodes and can reduce the risk of excessive bleeding during surgical procedures. The effects are typically observed within a short period after administration.

Precautions & Warnings

  • Betafact should be administered under medical supervision to ensure proper dosage and monitoring. It is important to inform healthcare providers about any allergies or pre-existing conditions before use. Proper storage and handling are essential to maintain the efficacy of the medication.

Avoid Interactions

  • Betafact may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be monitored as it can affect blood clotting.

Frequently Asked Questions

Betafact is used to manage bleeding episodes in individuals with hemophilia B by replacing the missing factor IX.

Betafact is administered intravenously, typically under medical supervision.

Betafact helps to stop bleeding episodes by promoting blood clotting, which is essential for individuals with hemophilia B.

Betafact should be used under medical supervision, and any allergies or pre-existing conditions should be disclosed to healthcare providers.

Betafact may interact with anticoagulants or antiplatelet drugs, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Ix

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT